Biogen Idec Intl GmbH

General

Total Cases17

Active Cases1

Patents--

CourtsD. Delaware C.D. California D. New Jersey

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

L3

E

PTAB

L5

A

CAFC

L3

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
10/31/22	Biogen Intl GmbH v. Amneal Pharma LLC 1:17-CV-00823 ( D. DE )	USCA Order Terminating Appeal as to 410 Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. USCA Decision: Appeal Dismissed. (mdb) (Entered: 10/31/2022)
10/31/22	Biogen Intl GmbH v. Hetero USA Inc 1:17-CV-00825 ( D. DE )	USCA Order Terminating Appeal as to 29 Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. USCA Decision: Appeal Dismissed. (mdb) (Entered: 10/31/2022)
04/11/22	Biogen Intl GmbH v. Torrent Pharma Ltd 1:17-CV-00854 ( D. DE )	CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb)
03/23/22	Biogen Intl GmbH v. Mylan Pharma Inc 1:17-CV-00116 ( N.D. WV )	MANDATE of USCA for the FEDERAL CIRCUIT as to 416 Notice of Appeal filed by Biogen International GMBH, Biogen MA, Inc. (cmd) (Entered: 03/23/2022)
03/16/22	Biogen Intl GmbH v. Mylan Pharma Inc 1:17-CV-00116 ( N.D. WV )	PRECEDENTIAL ORDER of USCA for the Federal Circuit filed denying 67 petition for panel rehearing and rehearing en banc filed by Biogen MA, Inc. and Biogen International GmbH. Lourie, Circuit Judge, with whom Moore, Chief Judge, and Newman, Circuit Judge, join, dissents from the denial of the petition for rehearing en banc as to 416 Notice of Appeal filed by Biogen International GMBH, Biogen MA, Inc. (cmd) (Entered: 03/16/2022) PRECEDENTIAL ORDER of USCA for the Federal Circuit filed denying 67 petition for panel rehearing and rehearing en banc filed by Biogen MA, Inc. and Biogen International GmbH. Lourie, Circuit Judge, with whom Moore, Chief Judge, and Newman, Circuit Judge, join, dissents from the denial of the petition for rehearing en banc as to 416 Notice of Appeal filed by Biogen International GMBH, Biogen MA, Inc. (cmd) (Entered: 03/16/2022)
11/30/21	Biogen Intl GmbH v. Mylan Pharma Inc 1:17-CV-00116 ( N.D. WV )	USCA FEDERAL CIRCUIT JUDGMENT as to 416 Notice of Appeal filed by Biogen International GMBH, Biogen MA, Inc. (dk) (Entered: 11/30/2021)
11/30/21	Biogen Intl GmbH v. Mylan Pharma Inc 1:17-CV-00116 ( N.D. WV )	USCA Federal Circuit Opinion as to 416 Notice of Appeal filed by Biogen International GMBH, Biogen MA, Inc. Federal Circuit Decision: AFFIRMED. (dk) (Entered: 11/30/2021)
10/23/20	Biogen Intl GmbH v. Alkem Laboratories Ltd 1:17-CV-00850 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [27] Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc. USCA Case Number 21-1091 (mdb)
10/23/20	Biogen Intl GmbH v. Sandoz Inc 1:17-CV-00874 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [26] Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc. USCA Case Number 21-1097 (mdb)
10/23/20	Biogen Intl GmbH v. Zydus Pharma USA Inc 1:17-CV-00954 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [20] Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc. USCA Case Number 21-1098 (mdb)